CClinicalTrials.gg
CompletedNCT02340754Updated Apr 9, 2018

Mindfulness-based Stress Reduction for Multiple Sclerosis

An interventional study of Mindfulness-based Stress Reduction and MS Education Control in Multiple Sclerosis, sponsored by National University of Natural Medicine. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-04-09.

Sponsored by National University of Natural Medicine · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
67
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The primary purpose of this study is to assess the feasibility of mindfulness-based stress reduction (MBSR) for adults with any type of multiple sclerosis. The secondary objectives are to: 1) Explore the ability of MBSR to improve perceived stress and quality of life compared to an education control group; and 2) Explore the durability of the effects of MBSR over one year.

02

Conditions studied

  • Multiple Sclerosis

Keywords

  • mindfulness
  • meditation
  • stress, psychological
  • quality of life
  • randomized controlled trial
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's enrollment of 67 is above the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

National University of Natural Medicine is the lead sponsor of 38 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Men and women 18 years of age or older
  • Definite relapsing remitting, secondary progressive, or primary progressive MS by revised McDonald criteria;
  • Expanded Disability Severity Scale ≤ 8 at baseline;
  • Stable on MS disease modifying, anxiolytic, or antidepressant medications for three months prior to baseline visit;
  • Mild to moderate stress defined by a score of ≥ 10 on the Perceived Stress Scale at screening;
  • Ability to read and write in English;
  • Willingness to provide informed consent and comply with study activities, including weekly MBSR sessions and daily practice or weekly Education Control classes.

Exclusion criteria

Exclusion Criteria:

  • MBSR or cognitive behavioral therapy training within the last 5 years;
  • Current regular meditation or yoga practice (weekly or more often);
  • MS exacerbation within 30 days of Baseline Visit;
  • Mini-Mental Status Examination (MMSE) score of ≤ 26 at Screening Visit;
  • Active suicidal ideation (Beck Depression Inventory) at Screening Visit;
  • Reported or medically recorded diagnoses of current serious psychological disorders other than depression and anxiety;
  • Other current life-threatening or severely disabling physical disorders;
  • Positive pregnancy urine test at Baseline and women planning pregnancy during the study period (contraception not required);
  • Cancer, other than basal or squamous skin cancers; or
  • Inability or unwillingness of individual or legal guardian/representative to give written informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
67 participants (actual)

Study arms

  • Experimental
    Mindfulness-base Stress Reduction

    Mindfulness-based stress reduction is a formalized, experiential, 8-week stress-management program. Participants attend weekly two-hour classes and a half-day retreat during which they learn mindfulness meditation, breath work, yoga postures, self-reflection and awareness.

    Behavioral: Mindfulness-based Stress Reduction

  • Active comparator
    MS Education Control

    The MS Education Control program is matched to MBSR for time and attention yet has no overlap with intervention content. Each two-hour class uses a pamphlet published by the National MS Society to present information about a different MS topic such as Fatigue; Bowel and Bladder Problems; Diet; Spasticity; and Nutritional Supplementation: Vitamins, Minerals, and Herbs.

    Behavioral: MS Education Control

Interventions

  • BehavioralMindfulness-based Stress Reduction

    Also known as: MBSR

  • BehavioralMS Education Control
06

What researchers measure

Primary outcomes

  1. Recruitment: Number of participants enrolled over a ten-month period

    Feasible recruitment is defined as the ability to recruit and enroll 60 participants with multiple sclerosis (MS) over a ten-month time frame. Recruitment rate will be calculated as the proportion of eligible patients who provided informed consent per month.

    Time frame: Recruitment will be tracked monthly with an expected recruitment period of 10 months..

  2. Adherence to Mindfulness-based Stress Reduction (MBSR): Number of Participants who are present for at least 5 of the classes, including the final class, and complete at least 70% of homework.

    Adherence will be tracked with a sign-in/sign out sheet at each class and with daily homework logs. Attendance will be calculated by a sign in/sign out sheet, being present for at least 75% of a class will count as attended. Homework will be tabulated as both a frequency count (number of days homework was completed) and amount (total number of minutes completed). Participants who are present for at least 5 of the classes, including the final class, and complete at least 70% of homework will be recorded as 'adherent'.

    Time frame: Baseline to 8 weeks

  3. Adoption: Qualitative assessment of facilitators of and barriers to participation in the MBSR program.

    Adoption is defined as the ability of participants to take part in activities such as yoga poses and meditative exercises. Qualitative outcomes include a brief, semi-structured focus group conducted at the beginning of the MBSR classes during weeks five and eight. Focus groups will address successes and any challenges participants may be experiencing. Focus groups will be audio recorded and transcribed verbatim for qualitative analysis.

    Time frame: Week 4 and week 8 of the 8 week intervention.

  4. Completion: Number of participants with complete follow-up at 12 months post-intervention.

    A feasible completion rate is defined as complete follow-up in at least 70% of enrolled subjects at 12-months post-intervention. Completion indicates acceptability of a long-term trial and will inform future study designs.

    Time frame: 14 months

Secondary outcomes

  1. Change from baseline in Perceived Stress Scale at 8 weeks

    Time frame: Baseline and 8 weeks

  2. Change in Perceived Stress Scale from 8 weeks to 12 months

    Time frame: 8 weeks and 12 months

  3. Change from baseline in Short Form-36 Mental Health Subscale to 8 weeks

    Mental health-related quality of life.

    Time frame: Baseline and 8 weeks

  4. Change in Short Form-36 Mental Health Subscale from 8 weeks to 12 months

    Mental health-related quality of life.

    Time frame: 8 weeks and 12 months

  5. Change in baseline Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety Score to 8 weeks

    PROMIS Computerized Adaptive Test of Anxiety

    Time frame: Baseline and 8 weeks

  6. Change in PROMIS Anxiety Score from 8 weeks to 12 months

    PROMIS Computerized Adaptive Test of Anxiety

    Time frame: 8 weeks and 12 months

  7. Change in baseline PROMIS Depression Score to 8 weeks

    PROMIS Computerized Adaptive Test of Depression

    Time frame: Baseline and 8 weeks

  8. Change in PROMIS Depression Score from 8 weeks to 12 months

    PROMIS Computerized Adaptive Test of Depression

    Time frame: 8 weeks and 12 months

  9. Change in baseline PROMIS Fatigue Score to 8 weeks

    PROMIS Computerized Adaptive Test of Fatigue

    Time frame: Baseline and 8 weeks

  10. Change in PROMIS Fatigue Score from 8 weeks to 12 months

    PROMIS Computerized Adaptive Test of Fatigue

    Time frame: 8 weeks and 12 months

  11. Change in baseline PROMIS Pain Score to 8 weeks

    PROMIS Computerized Adaptive Test of Pain

    Time frame: Baseline and 8 weeks

  12. Change in PROMIS Pain Score from 8 weeks to 12 months

    PROMIS Computerized Adaptive Test of Pain

    Time frame: 8 weeks and 12 months

07

Study locations

1 site
  • National College of Natural Medicine
    Portland, Oregon 97201, United States
08

References and documents

Publications

  • Senders A, Bourdette D, Hanes D, Yadav V, Shinto L. Perceived stress in multiple sclerosis: the potential role of mindfulness in health and well-being. J Evid Based Complementary Altern Med. 2014 Apr;19(2):104-11. doi: 10.1177/2156587214523291. Epub 2014 Feb 20. PubMed 24647090 ↗
  • Senders A, Sando K, Wahbeh H, Peterson Hiller A, Shinto L. Managing psychological stress in the multiple sclerosis medical visit: Patient perspectives and unmet needs. J Health Psychol. 2016 Aug;21(8):1676-87. doi: 10.1177/1359105314562084. Epub 2014 Dec 19. PubMed 25527612 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02340754
Lead sponsor
National University of Natural Medicine
Collaborators
National Institutes of Health (NIH), National Center for Complementary and Integrative Health (NCCIH)
Responsible party
Angela Senders, ND, MCR (Assistant Professor, National University of Natural Medicine) — Principal investigator
First posted
Jan 19, 2015
Start date
May 2015
Primary completion
May 30, 2017
Completion
May 30, 2017
Last update
Apr 9, 2018

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion